The Cost-Effectiveness of Dabigatran Etexilate Compared With Edoxaban in the Treatment of Acute Venous Thromboembolism in the Uk

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.831
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Cost-Effectiveness of Dabigatran Etexilate Compared With Rivaroxaban in the Treatment of Acute Venous Thromboembolism in the Uk

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Edoxaban for Treatment of Venous Thromboembolism in Patients With Cancer

Thrombosis and Haemostasis
Hematology
2015English

Cost-Effectiveness of Betrixaban Compared With Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients With Acute Medical Illness in the United States

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2018English

Cost-Effectiveness of Edoxaban Compared With Other Licensed Noacs for the Prevention of Stroke and Systemic Embolic Events in the Uk

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data

PLoS ONE
Multidisciplinary
2015English

Pcv85 - Cost-Effectiveness of Betrixaban Compared With Enoxaparin or Fondaparinux for Venous Thromboembolism Prophylaxis in Hospitalised Acute Medically Ill Patients in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Dabigatran Etexilate for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip and Knee Surgery: A Single Technology Appraisal

Health Technology Assessment
MedicineHealth Policy
2009English

Cost Effectiveness of Prophylaxis of Venous Thromboembolism

Journal of the Royal Society of Medicine
Medicine
1981English

Cost-Effectiveness Analysis of Treatment of Venous Thromboembolism With Rivaroxaban Compared With Combined Low Molecular Weight Heparin/Vitamin K Antagonist

Thrombosis Journal
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy